Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Impact of Body Mass Index on Immunogenicity of Pandemic H1N1 Vaccine in Children and Adults

Go back to Resources

Impact of Body Mass Index on Immunogenicity of Pandemic H1N1 Vaccine in Children and Adults

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Impact of a Genomic Classifier of Metastatic Risk on Post Prostatectomy Treatment Recommendations by Radiation Oncologists and Urologists

Go back to Resources

Impact of a Genomic Classifier of Metastatic Risk on Post Prostatectomy Treatment Recommendations by Radiation Oncologists and Urologists

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Experience in a Public Cord Blood Bank Using a Segment-Based Aldehyde Dehydrogenase Assay as a Biomarker for Umbilical Cord Blood Potency

Go back to Resources

Experience in a Public Cord Blood Bank Using a Segment-Based Aldehyde Dehydrogenase Assay as a Biomarker for Umbilical Cord Blood Potency

Authors:

Secondary:

Location:

URL:

Go back to Resources

Effect of Ranibizumab on High-Speed Indocyanine Green Angiography and Minimum Intensity Projection Optical Coherence Tomography Findings in Neovascular Age-Related Macular Degeneration

Go back to Resources

Effect of Ranibizumab on High-Speed Indocyanine Green Angiography and Minimum Intensity Projection Optical Coherence Tomography Findings in Neovascular Age-Related Macular Degeneration

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Ebola in the United States

Go back to Resources

Ebola in the United States

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

DNA Priming for Seasonal Influenza Vaccine: a Phase 1b Double-Blind Randomized Clinical Trial

Go back to Resources

DNA Priming for Seasonal Influenza Vaccine: a Phase 1b Double-Blind Randomized Clinical Trial

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Common Data Elements for Spinal Cord Injury Clinical Research: A National Institute for Neurological Disorders and Stroke Project

Go back to Resources

Common Data Elements for Spinal Cord Injury Clinical Research: A National Institute for Neurological Disorders and Stroke Project

Authors:

Secondary:

URL:

Abstract:

Go back to Resources

Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G(NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers

Go back to Resources

Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G(NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers

Authors:

Secondary:

Location:

URL:

Go back to Resources

Clindamycin Versus Trimethoprim-Sulfamethoxazole for Uncomplicated Skin Infections

Go back to Resources

Clindamycin Versus Trimethoprim-Sulfamethoxazole for Uncomplicated Skin Infections

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: Results From a Phase 1 Safety Trial

Go back to Resources

Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: Results From a Phase 1 Safety Trial

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 219
  • Page 220
  • Page 221
  • Page 222
  • Current page 223
  • Page 224
  • Page 225
  • Page 226
  • Page 227
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification